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National Enteric Disease Surveillance: 
Salmonella Surveillance Overview 
 
Surveillance System Overview: National Salmonella Surveillance  
Salmonella is estimated to cause more than 1.2 million illnesses each 
year in the United States, with more than 23,000 hospitalizations and 
450 deaths (1).   Salmonella infections most often cause 
gastroenteritis which can range from mild to severe; invasive 
infections can be severe and potentially life threatening. 
National Salmonella surveillance data are collected through passive 
surveillance of laboratory-confirmed human Salmonella isolates.  
Clinical diagnostic laboratories submit Salmonella isolates to state and 
territorial public health laboratories, where they are confirmed and 
serotyped according to the Kauffmann-White scheme.  Unusual or 
untypable serotypes are forwarded to the Centers for Disease Control 
and Prevention’s (CDC) National Salmonella Reference Laboratory at 
the Enteric Diseases Laboratory Branch (EDLB) for further 
characterization or confirmation; results are reported back to state 
and territorial public health laboratories.  State and territorial public 
health laboratories send reports electronically to CDC through a 
variety of mechanisms.  Initially, all surveillance data were transmitted 
through the Public Health Laboratory Information System (PHLIS), 
but other methods of data transmission have been implemented over 
time; currently data are collected into the Laboratory-based Enteric 
Disease Surveillance (LEDS) system, which has replaced PHLIS.  The 
Division of Foodborne, Waterborne, and Environmental Diseases 
(DFWED) in the National Center for Emerging and Zoonotic Infectious 
Diseases maintains the national Salmonella surveillance data in LEDS. 
The annual summaries of these data are the only regularly published 
national source of serotype information for Salmonella (2).   
Isolates are reported by state and represent the state where 
laboratory confirmation and subtyping occurred; the reporting state 
may not be the same as the state of residence of the person from 
whom the isolate was obtained.  Reports include basic demographic 
information, serotype, and specimen source. For Salmonella serotype 
Typhi, only the first isolation in a calendar year for each person is 
counted.  For serotypes other than Typhi, only the first isolation 
within a thirty day period for each person is counted, if the serotype 
and clinical source (e.g., stool or blood) are the same.   
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Rates of isolation are reported, but the rates of incomplete and unknown serotype data vary by 
state and year, as do reporting rates.  The national Salmonella surveillance data are dynamic; data 
from previous years may change as isolate reports are added or corrected. 
Salmonella isolates from animals and related sources (e.g., environment and feeds) are submitted 
by animal disease diagnostic laboratories and United States Department of Agriculture (USDA), 
Food Safety and Inspection Service (FSIS) laboratories throughout the United States to the Animal 
and Plant Health Inspection Services, National Veterinary Services Laboratories 
(USDA/APHIS/NVSL) for serotyping (3).  Salmonella serotype data from animals and related 
sources that NVSL receives from other US laboratories are also included.  Clinical animal (referred 
to as “clinical/non-human”) isolates are defined as Salmonella isolates from animals with clinical 
signs of salmonellosis; Salmonella isolates identified through herd and flock monitoring and 
surveillance, feed sample testing, environmental testing, and USDA FSIS food testing programs 
are designated “non-clinical/non-human” isolates.  Samples originating from non-human sources 
are tested for Salmonella for a variety of purposes and are obtained in multiple ways.  Sampling is 
therefore neither complete nor representative, and any interpretation of these data should 
consider these limitations. 
Although all Salmonella infections are nationally notifiable, for several reasons many cases are 
likely not recognized.  Not all persons ill with Salmonella infection seek medical care, healthcare 
providers may not obtain a specimen for laboratory diagnosis, or the clinical diagnostic laboratory 
may not perform the necessary diagnostic tests.  Additionally, not all Salmonella isolates may be 
forwarded or reported to state public health laboratories and are therefore not reported to 
national-level surveillance (4).   
Other sources of national-level Salmonella surveillance data 
Several other systems at CDC conduct surveillance for Salmonella infection.  The National 
Notifiable Diseases System (NNDSS) collects and compiles reports of nationally notifiable 
infectious diseases, including salmonellosis (5).  NNDSS collects data from states on both 
laboratory-confirmed and probable cases of infection (probable cases are defined as clinically ill 
persons with an epidemiological link to a confirmed case).  NNDSS data is collected from states in 
a number of mechanisms, including the National Electronic Diseases Surveillance System (NEDSS) 
which is being developed to integrate both epidemiologic and laboratory information; currently 
laboratory information is not available from NNDSS.  The National Antimicrobial Resistance 
Monitoring System (NARMS) monitors antimicrobial resistance among enteric bacteria (including 
Salmonella) from humans, retail meats, and food animals (6).  The National Outbreak Reporting 
System (NORS) collects reports of foodborne, waterborne, enteric person-to-person, and animal 
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Overview of Salmonella Taxonomy and Serotype Nomenclature 
I. Salmonella Taxonomy 
The genus Salmonella is divided into two species, enterica and bongori. The species Salmonella 
enterica is further subdivided into six subspecies that are designated by taxonomic names; these 
are sometimes abbreviated by Roman numerals.  The Roman numeral designations are used in 
designating serotypes by formula.   
 
Salmonella enterica subspecies 
I Salmonella enterica subsp. enterica 
II Salmonella enterica subsp. salamae 
IIIa Salmonella enterica subsp. arizonae 
IIIb Salmonella enterica subsp. diarizonae 
IV Salmonella enterica subsp. houtenae 
VI Salmonella enterica subsp. indica 
  
Subspecies IIIa and IIIb were originally considered a separate genus, Arizonae, and are still 
sometimes referred to by this name, although it is obsolete. Despite this common history, 
subspecies IIIb is more closely related to the other Salmonella enterica subspecies than to 
subspecies IIIa. 
Salmonella bongori was originally designated S. enterica subspecies V; it has since been 
determined to be a separate species of Salmonella.  However, for simplicity and convenience, 
these strains are still sometimes referred to as “subspecies V”.    
II. Salmonella Serotypes   
Serotyping is a subtyping method used to differentiate isolates of Salmonella beyond the 
subspecies level.  Salmonella serotypes are designated based on the immunoreactivity of two cell 
surface structures, the O and H antigens. A substantial amount of diversity exists in these two 
antigens, resulting in the designation of more than 2,500 serotypes and the regular recognition of 
new serotypes.  
There are national Salmonella surveillance data by serotype going back to 1963.  Serotyping is an 
essential component of epidemiological surveillance and investigation of outbreaks of 
salmonellosis. Pulsed-field gel electrophoresis (PFGE) pattern characterization provides further 
subtyping.  Historically, serotypes were considered different species (e.g., Salmonella enterica 
serotype Typhimurium was originally designated Salmonella typhimurium).  It is now known that 
different serotypes of Salmonella can be closely related both phenotypically and genetically; 
serotypes are not intended as taxonomic designations.   
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IIa. Salmonella Serotype Antigens   
The O antigen is a carbohydrate (polysaccharide) antigen that is the outermost component of the 
cell surface lipopolysaccharide.  It is a polymer of O subunits and is typically composed of four to 
six sugars.  Differences between O antigens can result from: 
• the sugar components of the O subunit, 
• the nature of the covalent bond between the sugars within the O subunit, or 
• the nature of the linkage between the O subunits that form the O antigen polymer. 
Specific epitopes within O antigens are divided into two categories: O group antigens and ancillary 
O antigens.  O group antigens are associated with the core sugar configuration of the O antigen 
structure; O groups are designated by the primary O epitopes that are associated with the group.  
Ancillary O antigens are additional carbohydrates that are added to the core O antigen structure.  
They are associated with specific O serogroups and are often variably present or variably 
expressed.   
Each O epitope is designated by a number; however, many of the common O groups were 
originally designated by letter and are still commonly referred to this way (e.g., serotype 
Typhimurium belongs to Group O:4 or Group B, serotype Enteritidis belongs to group O:9 or 
Group D1; serotype Paratyphi A belongs to Group O:2 or Group A).  When multiple O epitopes are 
present, they are listed sequentially and separated by commas. Table A lists the 46 described O 
groups and the ancillary O antigens that may be present in serotypes of that group.   
The H antigen is the filamentous portion of the bacterial flagellum; it is made up of protein 
subunits called flagellin.  The C’ and N’ termini of flagellin, which give the flagellum its 
characteristic filamentous structure, are conserved.  The antigenically variable portion of flagellin 
is the middle region, which is exposed on the surface of the flagellum. Salmonella is unique among 
enteric bacteria in that it can express two different flagellin antigens. The two antigens are 
referred to as Phase 1 and Phase 2.  Typically, only one antigen is expressed at a time in a single 
bacterial cell. “Monophasic” isolates are those that express only a single flagellin type.  These 
occur naturally for some serotypes (e.g., serotypes Enteritidis, Typhi, and most subspecies IIIa and 
IV serotypes) or can occur through the loss or lack of expression of a flagellin gene.   
Table B lists the H antigens of Salmonella.  Some antigens are composed of multiple factors, which 
are separated by commas in the formula; for example, the second phase antigen of  serotype 
Typhimurium is composed of factors 1 and 2, which is represented as “1,2”.  Related antigens are 
grouped into complexes.   For example, the 1 complex is composed of flagellar antigens 1,2; 1,5, 
1,6 and 1,7. 
IIb. Salmonella Serotype Identification  
Salmonella serotypes are typically identified through a series of tests.  Isolates are first identified 
to the genus and species level.  The subspecies is then determined, typically by biochemical 
testing.  O and H antigens are detected in independent agglutination assays using antisera that 
react with groups of related antigens or a single antigen.  Both H antigens can sometimes be 
detected in a single culture, particularly for older strains or for isolates that have been passed 
multiple times.  When only one H antigen is detected, the isolate is inoculated onto phase reversal 
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media, a semisolid media containing antisera to the H antigen that has already been identified.  
Organisms expressing the previously detected H antigen are immobilized by the antisera and grow 
only near the point of inoculation. Organisms expressing the second H antigen are able to move 
away from the point of inoculation, evidenced by growth throughout the media.  The second H 
antigen is then determined using isolates from the phase reversal media.  
IIc. Salmonella Serotype Designation  
Salmonella serotypes are designated according to the conventions of the Kauffmann-White 
Scheme.  The Kauffmann-White Scheme is maintained by the WHO Collaborating Centre for 
Reference and Research on Salmonella at the Institut Pasteur and is used by most public health 
laboratories worldwide (8).  All Salmonella serotypes can be designated by a formula; subspecies I 
serotypes are also given a name (e.g., Typhimurium, Enteritidis, Typhi).   
The typical format for a serotype formula is:  
Subspecies [space] O antigens [colon] Phase 1 H antigen [colon] Phase 2 H antigen  
Examples:   
I 4,5,12:i:1,2  (S. enterica serotype Typhimurium)  
I 4,12:i:1,2 (S. enterica serotype Typhimurium var. O:5-)  
I 9,12:g,m:- (S. enterica serotype Enteritidis)  
II 47:b:1,5 (S. enterica serotype II 47:b:1,5)  
IV 48:g,z51:- (S. enterica serotype IV 48:g,z51:-)  
IIIb 65:(k):z (S. enterica serotype IIIb 65:(k):z)  
Other conventions:  
• Some O and H epitopes are present variably. When the variable epitope is known to 
be encoded by a bacteriophage it is underlined (e.g., O20 is designated O:8,20 in 
some serogroup C2 serotypes).  Bacteriophage-encoded antigens have only been 
described for O antigens.  When the basis for variability is not known, the antigenic 
factor is placed in square brackets (e.g., O5 is designated O:4,[5],12 in some 
serogroup B serotypes). For an individual isolate, if the variable factor is detected it 
is included in the formula without additional notation (i.e., without underlining or 
square brackets). If the variable factor is not detected, it is not listed in the formula. 
• Some O and H factors are variably expressed.  Weakly recognized antigens are 
indicated by parentheses (e.g., O antigen (6),14 or H antigen (k)).  
• “Serotype” and “serovar” are used interchangeably. 
• In monophasic isolates, the absence of an H antigen is indicated by a minus sign (“-
“) for the particular phase. 
• Variants of serotypes that do not express all the recognized antigens characteristic 
of that particular serotype are not uncommon.  This is a particular issue for 
subspecies I serotypes, because a serotype name cannot be assigned unless all the 
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antigens specified in the Kauffmann-White scheme for that serotype are identified. 
Isolates missing one or more antigens are designated by a formula. For example: 
a) Monophasic variants are variants of serotypes that are typically diphasic; 
they lack the expression of either the flagellar Phase 1 or Phase 2 antigen.  
These are indicated by a minus sign (“-“) in place of the missing phase (e.g., 
monophasic variants of serotype Typhimurium lacking the second phase H 
antigen, 1,2, are designated as Salmonella serotype I 4,5,12:i:- or I 4,12:i:-; 
monophasic variants of serotype Typhimurium that lack the first phase H 
antigen, i, are designated as serotype I 4,5,12:-:1,2 or I 4,12:-:1,2). 
b) Nonmotile variants express no H antigens and are indicated by minus signs 
in both phases or by “nonmotile” in place of the H antigens (e.g., serotype I 
4,5,12:nonmotile or I 4,5,12:-:-) 
c) Rough variants are isolates that do not express O antigen. This is indicated 
by “Rough” in place of the O antigen in the antigenic formula (e.g., serotype 
I Rough:i:1,2). 
d) Mucoid variants express a capsule that prevents immunologic detection of 
the O antigen. They are indicated by “Mucoid” in place of the O antigen in 
the antigenic formula (e.g., serotype I Mucoid:i:1,2).   
• Rarely, isolates express a third H antigen that is noted by a colon followed by the 
antigen after the Phase 2 H antigen (e.g., serotype II 9,12:g,m,[s],t:1,5,7:z42, in 
which antigen z42 is the third H antigen). 
All serotype information should be submitted to LEDS, whether or not a serotype “name” can be 
assigned to a strain.  Monophasic, nonmotile, rough, and mucoid strains should be reported by 
formula indicating the antigens that were detected, as described above  
III.  Modified Kauffmann-White Scheme 
CDC used a modified Kauffmann-White Scheme through 2002, and then changed to the 
Kauffmann-White Scheme to improve the comparability of United States Salmonella surveillance 
data with data from other countries.   The primary differences between the two schemes are the 
following: 
• Under the Kauffmann-White Scheme, subspecies I serotypes are named; subspecies 
II through VI serotypes are identified by formula.  The Modified Kauffmann-White 
Scheme used names for subspecies II through VI serotypes through 1968 and 
formulas for subspecies II through VI serotypes after 1968.  The most common 
serotypes that do not belong to subspecies I and were affected by the change to the 
Kauffman-White Scheme are 
a) Serotype Marina (now designated as IV 48:g,z51:-) 
b) Serotype Flint (now designated as IV 50:z4,z23:-) 
c) Serotype Kralendyk (now designated as IV 6,7:z4,z24:-) 
d) Serotype Chameleon (now designated as IV 16:z4,z32:-) 
 
• Under the Kauffmann-White Scheme, serogroups E2 and E3 were combined with 
serogroup E1, because the antigenic changes in serogroups E2 and E3 are the result 
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of lysogenic conversion by bacteriophages and thus represent minor variants of 
serogroup E1 serotypes, designated as “variety” or “var.”.  The Modified 
Kauffmann-White Scheme used separate serotype names for these variants.  Two 
common serotypes were affected by the merging of serogroups E2 and E3 with 
serogroup E1: 
a) Serotype Newington (now Anatum var. 15+ 
b) Serotype Newbrunswick (now Give var. 15+) 
 
• Under the Kauffmann-White Scheme, two biotypes of serotype Paratyphi B are 
recognized; they are differentiated primarily by the ability to ferment tartrate.  
Serotype Paratyphi B is tartrate-negative (unable to ferment tartrate) and is 
associated with severe, typhoid fever-like disease.  Serotype Paratyphi B var. 
L(+)tartrate+ (formerly Java) is tartrate-positive (able to ferment tartrate) and is 
commonly associated with gastroenteritis.   The two biovars of Paratyphi B can be 
confused because they have the same antigenic formula (I 4,[5],12:b:1,2), and are 
typically differentiated only by the ability to ferment tartrate, although PCRs that 
detect specific virulence markers are becoming more common.  Given the very 
different disease syndromes caused by these two biotypes, it is important to 
accurately identify and report the two biotypes. 
After the 2004 Salmonella Surveillance Summary was published, serotype designations for many 
isolates that were submitted during 1995 through 2003 were updated in the national Salmonella 
surveillance database using additional information submitted to CDC by states; previous 
surveillance summaries were not updated to reflect these change.  CDC now uses all information 
submitted with the isolate, including information in the comments field, to characterize isolates 
more completely.  This has affected the national Salmonella database in the following ways: 
• Reporting of Salmonella serotype I 4,[5],12:i:- was inconsistent in the past due to 
variability in the nomenclature used to report this serotype, resulting in many 
isolates being reported only as “Group B” or “Subspecies I” and some isolates being 
incorrectly reported as serotype Typhimurium;  
• Most variants of serotypes (monophasic, nonmotile or rough isolates) were not 
listed by their variant formulas before 2002, but were reported only by O group or 
subspecies.  Since 2002, all serotype variants have been converted to standard 
serotype formulas whenever possible and incorporated into the surveillance 
database and reports;   
• Serotypes of subspecies other than I were not listed in CDC surveillance summaries 
before 2002; instead, these isolates were reported by O group or subspecies only.  
Beginning in 2002, all serotype formulas that were submitted to the national 
surveillance system, regardless of subspecies, have been incorporated into the 
surveillance database and reported in surveillance summaries;  
• In 2002, CDC modified the designation and reporting of partial serotype data.  
Before 2002, partially serotyped isolates were reported primarily by serogroup. 
Serogroups A–E are primarily composed of subspecies I serotypes, but most other 
July 2011  Page 8 of 12 
 
serogroups (F through Z) include serotypes from more than one subspecies.  
Therefore, when full serotype information is not available, isolates are reported first 
by subspecies, then O group and any additional serotype antigens.   
IV. Abbreviating Salmonella Serotype Designations 
As described above, the complete, formal designation of a Salmonella serotype is its genus-
species or genus-species-subspecies name, followed by “serotype” and the serotype name or 
formula.  
Some examples are: 
Salmonella enterica subspecies enterica serotype Typhimurium 
Salmonella enterica serotype Typhimurium 
S. enterica serotype Typhimurium 
S. enterica  subspecies salamae  serotype 47:b:1,5 
S. enterica  serotype II 47:b:1,5 
 
Some scientific journals require the formal designation of serotypes throughout a paper; others 
allow the use of an abbreviation. However, there is no international standard for abbreviating 
Salmonella serotypes.   
Because in the past, serotype names were written as species, and because inconsistencies in 
nomenclature still occur, it is helpful to include the word “serotype”, which can be abbreviated 
“ser.”, in a serotype abbreviation.  
Examples of clear abbreviations are: 
Salmonella serotype Typhimurium 
Salmonella ser. Typhimurium 
Salmonella serotypes Typhimurium, Enteritidis, and Newport  
 
A commonly used but undesirable abbreviation designates the genus- name as “S.”, omits the 
species name, and is followed by the serotype name (e.g., S. Typhimurium).  
 
This format has the following disadvantages: 
• It can be misinterpreted as giving species/taxonomic standing to serotypes.  
• It is formatted as a taxonomic designation.  However, serotypes have no taxonomic 
standing, and this abbreviation is not correct taxonomically. To be taxonomically 
correct, the name must include species (e.g., S. enterica ser. Typhimurium). 
• “S. ” could mean Shigella, Serratia, Sutterella, or any of a number of genera.  This is 
most likely to be a problem with less common serotypes or when a variety of genera 
are being considered.  
• “S. Cholerasuis” and “S. Enteritidis” were historically used as taxonomic species 
names. The incorrect abbreviations “S. Cholerasuis” and “S. Enteritidis”, which are 
intended to denote serotypes, are difficult to differentiate from the historical 
species names, which are sometimes still used and found in the literature. 
July 2011  Page 9 of 12 
 
V. Salmonella Serotype Statistics  
As of 2007, 2,579 Salmonella serotypes had been described; about 60% belong to subspecies I.  In 
the United States, 99% of reported human Salmonella isolates belong to subspecies I. The 20 most 
common serotypes from human specimens account for about 70% of all isolates reported in the 
United States; the top 100 serotypes account for about 98% of all isolates.  In 2007, subspecies 
other than I were among the 100 most commonly isolated serotypes.  These included two 
subspecies IV serotypes (IV 50:z4,z23:-; IV 48:g,z51:-;) and non-serotyped subspecies II, IIIa/IIIb,  
IIIb, and IV isolates.  In general, subspecies IV isolates are the most commonly isolated subspecies 
other than I (particularly serotypes IV 48:g,z51:-; IV 50:z4,z23:-; IV 6,7:z4,z24:-; and IV 16:z4,z32-), 
followed by subspecies IIIb, II, and IIIa.  Subspecies VI and S. bongori isolates are very rare.  
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Table A.  Salmonella O groups and associated O antigens 
O Group (number 
designation) 
O Group (letter 
designation 
Antigens present in 
all serotypes 
Additional antigens that may be 
present in some serotypes 
2  A  2,12  1  
4  B  4,12  1; 5; 27  
7  C1  6,7  14; (Vi)  
8  C2  8  6; 20  
9  D1  9,12  1; (Vi)  
9,46  D2  9,46  none  
9,46,27  D3  9,12,46,27  1  
3,10  E1  3,10  15; 15,34  
1,3,19  E4  1,3,19  10; 15  
11  F  11  none  
13  G  13  1; 22; 23  
6,14  H  6,14  1; 24; 25  
16  I  16  none  
17  J  17  none  
18  K  18  6; 14  
21  L  21  none  
28  M  28  none  
30  N  30  none  
35  O  35  none  
38  P  38  none  
39  Q  39  none  
40  R  40  1  
41  S  41  none  
42  T  42  1  
43  U  43  none  
44  V  44  1  
45  W  45  none  
47  X  47  1  
48  Y  48  none  
50  Z  50  none  
51    51  1  
52    52  none  
53    53  1  
54 (provisional)    54  21; 3; 3,15; 4,12; 8,20; 6,7  
55    55  none  
56    56  none  
57    57  none  
58    58  none  
59    59  1  
60    60  none  
61    61  none  
62    62  none  
63    63  none  
65    65  none  
66    66  none  
67     67  none  
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Table B.  H (flagellar) antigens of Salmonella 
1 complex:  
   
   
   
   
   
   
   
1,2  Other antigens 









































   
a  
1,5  b  
1,6  c  
1,7  d  
1,2,5  e,h  
1,2,7  i  
1,5,7  k  
1,6,7  (k)  
EN complex:  
   
   
e,n,x  r  
e,n,x,z15  r,i  
e,n,z15  y  
G complex:  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
f,g  z  
f,g,m,t  z6  
f,g,s  z10  
f,g,t  z29  
g,m  z35  
g,m,p,s  z36  
g,m,q  z36,z38  
g,m,s  z38  
g,m,s,t  z39  
g,m,t  z41  
g,p  z42  
g,p,s  z44  
g,p,u  z47  
g,q  z50  
g,s,q  z52  
g,s,t  z53  
g,t  z54  
g,z51  z55  
g,z62  z56  
g,z63  z57  
g,z85  z60  
m,p,t,u  z61  
m,t  z64  
L complex:  
   
   
   
   
l,v  z65  
l,w  z67  
l,z13  z68  
l,z13,z28  z69  
l,z28  z71  
Z4 complex:  
   
   
   
z4,z23  z81  
z4,z23,z32 z83  
z4,z24  z87  
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